Each year, CMS contacts a random sample of Medicare Advantage plan members for its Health Outcomes Survey (HOS) for feedback on experiences with providers and health plans. For 2025, surveys began mailing July 21. Some of your patients may receive a survey. To shed...
CMS established the following new medication-related quality measures for the 2025 measurement year: Concurrent Use of Opioids and Benzodiazepines Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults Read on to learn more about the measures to...
From March through May each year, a random sample of your Medicare Advantage patients receive the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) survey, which helps provide feedback on patients’ experiences. Experience—not the same as...
Annual kidney disease testing and monitoring is crucial for people with diabetes, as diabetes is the leading cause of chronic kidney disease. Yet fewer than 50% of patients with diabetes receive both eGFR and uACR tests—those recommended under the Kidney Health...